Similar Articles
481 Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma
482 Association between direct-acting antiviral agents in hepatitis C virus treatment and hepatocellular carcinoma occurrence and recurrence: The endless debate
483 Will the collaboration of surgery and external radiotherapy open new avenues for hepatocellular carcinoma with portal vein thrombosis?
484 Frankincense myrrh attenuates hepatocellular carcinoma by regulating tumor blood vessel development through multiple epidermal growth factor receptor-mediated signaling pathways
485 Validation of the PAGE-B score to predict hepatocellular carcinoma risk in caucasian chronic hepatitis B patients on treatment
486 Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions
487 Targets of immunotherapy for hepatocellular carcinoma: An update
488 Application value of mixed reality in hepatectomy for hepatocellular carcinoma
489 Molecular and genetic markers in hepatocellular carcinoma: In silico analysis to clinical validation (current limitations and future promises)
490 Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA